U09.9 F06.7 I64
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: - Age 50-80 years - community dwelling able to walk 500-m independently or with a stick - Montreal Cognitive Assessment - MOCA score > 23 (the Montreal Cognitive Assessment is a validated rapid screening test of language, memory, attention, visual/spatial, reasoning, orientation skills) - Depression subscale on Hospital Anxiety and Depression Scale < 10/21 (14-item questionnaire) - No significant visual impairment (as self-reported by participants) - Willing to comply with study procedures, proposed training and testing regime - With capacity to consent - Fulfilling all of the criteria from one of the below sub-groups
Exclusion criteria
Exclusion criteria: - Outside of the stated age bracket - Unable to walk independently (even with use of a walking stick) - MOCA score <23 - Score of 10 or higher on depression subscale of HADS - Unwilling to comply with study procedures, proposed training and testing regime - No capacity to consent - Significant visual impairment (self-reported) • Orthostatic hypotension or uncontrolled hypertension • Other neurological problem (e.g. Parkingson’s disease, Multiple Sclerosis etc.) • Language and communication deficits impairing ability to express thoughts (e.g. Aphasia) • Has participated in a clinical drug trial in the past 6 months. • Acute musculoskeletal injury that prevents participation in a structured exercise programme (e.g. lower limb fracture). • Has an implanted medical device or cardiac pacemaker. - Not fulfilling the inclusion criteria for one of the sub-groups (such as criteria for Stroke group, or MCI group, or chronic vestibular disorder group, or long-Covid group)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The primary aim of this study is to evaluate the developed hologram trainer in combination with automatic training progression through artificial intelligence in terms of socioeconomic costs in the healthcare system, as well as the quality of life of the participants. | — |
Secondary
| Measure | Time frame |
|---|---|
| The secondary outcomes aim to improve balance ability (Mini-BESTest and FGA), gait function (TUG), balance confidence (ABC scale), fear of falling (FES-I), fall prediction (keeping a diary), cognitive impairment (MoCA), mood (Hospital Anxiety and Depression Scale), and daily physical activity. | — |
Countries
Germany, Greece, Portugal, Thailand, United Kingdom
Contacts
Universitätsklinikum Freiburg, Department Neurozentrum, Neurologie und Neurophysiologie - Abteilung klinische Forschung